CMCécile E. Malnou

Cécile E. Malnou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cécile E. Malnou has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Placental Extracellular Vesicles Exhibit Reduced Neurogenic Potential Linked to Changes in Their miRNA Landscape Upon HCMV Infection

    by Charlène Martin, Hélène Martin, Mathilde Bergamelli, Lhorane Lobjois, Lucie Franco, Emma Bordes, Alexandra Benchoua, Stéphanie Balor, Diala Kantar, Etienne Coyaud, et al.

    Extracellular vesicles (EVs) are key mediators of maternal–foetal communication, regulating placental function and foetal development through the transfer of bioactive molecules. Although placental EVs play a crucial role in placental function during pregnancy, their contribution to foetal development, notably foetal brain, remains poorly understood. Human cytomegalovirus (HCMV) is the most common virus transmitted in utero and a leading cause of infectious brain malformations. Although certain central nervous system lesions caused by HCMV are explained, the neuropathogenesis of congenital infection remains poorly understood. In this study, we demonstrate that EVs from healthy placentas promote neurogenesis. However, EVs from HCMV‐infected placentas lose this neurogenic potential, impairing differentiation and migration of neural stem cells, perturbations that may contribute to the neurodevelopmental defects observed in congenital HCMV infections. miRNA profiling revealed profound infection‐induced changes, including the incorporation of viral miRNAs and dysregulation of host miRNAs involved in neurogenesis. These findings highlight the critical role of placental EVs in foetal brain development and their contribution to HCMV neuropathogenesis.


  • Open Access

    JoVE Video Dataset

    by Hélène Martin, Charlène Martin, Loïc Guimbaud, Delphine Duchanois, Paul Guerby, Cécile E. Malnou

    The placenta plays a critical role during pregnancy, enabling maternal-fetal exchange while serving as a barrier against pathogens. However, some viruses, including human cytomegalovirus (HCMV) or Zika virus (ZIKV), can cross this barrier and cause congenital infections, leading to severe fetal outcomes such as growth restriction, impairment of brain development, or fetal demise. Understanding how viruses infect and disseminate through the placenta is therefore essential. To investigate viral vertical transmission in a physiologically relevant context, an ex vivo model using human placental explants cultured at the air-liquid interface on gelatin sponges can be used and offers several advantages. Unlike conventional in vitro systems limited to single-cell types, this model preserves the multicellular structure and function of the placental tissue for up to three weeks. This model is compatible with a wide range of upstream experimental applications (histological analyses, RT-qPCR, TUNEL assay, quantification of secreted factors, etc.), making it a robust and accessible platform to study viral replication, immune responses, and placental barrier function under near-physiological conditions.

  • Open Access

    Ex vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface

    by Hélène Martin, Charlène Martin, Loïc Guimbaud, Delphine Duchanois, Paul Guerby, Cécile E. Malnou

    The placenta plays a critical role during pregnancy, enabling maternal-fetal exchange while serving as a barrier against pathogens. However, some viruses, including human cytomegalovirus (HCMV) or Zika virus (ZIKV), can cross this barrier and cause congenital infections, leading to severe fetal outcomes such as growth restriction, impairment of brain development, or fetal demise. Understanding how viruses infect and disseminate through the placenta is therefore essential. To investigate viral vertical transmission in a physiologically relevant context, an ex vivo model using human placental explants cultured at the air-liquid interface on gelatin sponges can be used and offers several advantages. Unlike conventional in vitro systems limited to single-cell types, this model preserves the multicellular structure and function of the placental tissue for up to three weeks. This model is compatible with a wide range of upstream experimental applications (histological analyses, RT-qPCR, TUNEL assay, quantification of secreted factors, etc.), making it a robust and accessible platform to study viral replication, immune responses, and placental barrier function under near-physiological conditions.